DRUG SPENDING
TODAY'S HEADLINES
The US growth rate for spending on medicines is expected to fall in 2016 and beyond, new research says. Read more |
|
FDA recently approved a new indication for bevacizumab (Avastin) to treat patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Read more
|
CONTINUING PHARMACY EDUCATION
This month's CE activity, "Key cogs in the management of Parkinson's disease," is open for pharmacists and pharmacy technicians.
The goal of this activity is to assist pharmacists and pharmacy technicians in managing difficult-to-treat symptoms of Parkinson's disease.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More
|
EDITOR'S PICK
FDA's approval of a new indication for empagliflozin (Jardiance) could net one pharma company more than $1 billion. Read more |
|
|
